These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
596 related articles for article (PubMed ID: 8774138)
1. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138 [TBL] [Abstract][Full Text] [Related]
2. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. Jiang SX; Kameya T; Shinada J; Yoshimura H Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in non-small cell lung carcinomas. Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of neural-cadherin in pulmonary epithelial tumours. Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586 [TBL] [Abstract][Full Text] [Related]
5. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288 [TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
7. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma. Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784 [TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148 [TBL] [Abstract][Full Text] [Related]
9. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors. Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739 [TBL] [Abstract][Full Text] [Related]
10. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha). Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258 [TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Lyda MH; Weiss LM Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260 [TBL] [Abstract][Full Text] [Related]
12. Bcl-2 protein expression correlates with nodal status in non small cell lung cancer. Groeger AM; Caputi M; Esposito V; De Luca A; Salat A; Murabito M; Giordano GG; Baldi F; Giordano A; Wolner E Anticancer Res; 1999; 19(1B):821-4. PubMed ID: 10216499 [TBL] [Abstract][Full Text] [Related]
13. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung. Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762 [TBL] [Abstract][Full Text] [Related]
14. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766 [TBL] [Abstract][Full Text] [Related]
15. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma. Graff L; Castrop F; Bauer M; Höfler H; Gratzl M Cancer Res; 2001 Mar; 61(5):2138-44. PubMed ID: 11280778 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of bcl-2 protein in adenocarcinoma and non-neoplastic cellular compartments of the lung. Rao SK; Krishna M; Woda BA; Savas L; Fraire AE Mod Pathol; 1996 May; 9(5):555-9. PubMed ID: 8733771 [TBL] [Abstract][Full Text] [Related]
17. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Nakamura N; Miyagi E; Murata S; Kawaoi A; Katoh R Mod Pathol; 2002 Oct; 15(10):1058-67. PubMed ID: 12379752 [TBL] [Abstract][Full Text] [Related]
18. The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes. Berrieman HK; Smith L; O'Kane SL; Campbell A; Lind MJ; Cawkwell L Cancer; 2005 Apr; 103(7):1415-9. PubMed ID: 15700269 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study. Visscher DW; Zarbo RJ; Trojanowski JQ; Sakr W; Crissman JD Mod Pathol; 1990 Jul; 3(4):508-12. PubMed ID: 2170973 [TBL] [Abstract][Full Text] [Related]
20. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage. Ito T; Noguchi Y; Satoh S; Hayashi H; Inayama Y; Kitamura H Mod Pathol; 1998 May; 11(5):437-43. PubMed ID: 9619596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]